izpis_h1_title_alt

Matrixing designs for shelf-life determination of parenteral drug product : a comparative analysis of full and reduced stability testing design
ID Pavčnik, Lara (Avtor), ID Locatelli, Igor (Avtor), ID Trdan Lušin, Tina (Avtor), ID Roškar, Robert (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (697,77 KB)
MD5: 81394D5CDAE888046F11CA003BBBB5AD
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/1999-4923/16/9/1117 Povezava se odpre v novem oknu

Izvleček
This article highlights the applicability of matrixing designs in stability studies for parenteral medications. The traditional approach involves extensive testing over the product’s shelf-life. However, matrixing designs offer an alternative approach where only a fraction of samples is tested at each time point. The study conducted in this article focused on three parenteral medications and examined stability data under long-term condition. Degradation products were identified as critical parameter, and kinetics of degradation varied among the selected products. A systematic methodology was adopted to evaluate the data using different matrixing designs. The regression models obtained were assessed using statistical parameters S and R$^2$. Also, each of the 28 matrixing designs were compared to the full design with statistical parameter RMSE and the shelf-life. The results confirmed that each of the evaluated matrixing designs can be applied, whether degradation product shows a linear or non-linear increase, and demonstrated that a reduction of two time points per batch is the most appropriate. In conclusion, this research contributes to the understanding of utilizing reduced matrixing designs in stability studies for parenteral medications and can be an effective strategy to reduce costs and time of stability testing while maintaining the necessary level of precision and reliability.

Jezik:Angleški jezik
Ključne besede:shelf-life, matrixing design, ICH Q1D, stability study, degradation kinetics, parenteral dosage forms
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2024
Št. strani:12 str.
Številčenje:Vol. 16, iss. 9, art. 1117
PID:20.500.12556/RUL-162173 Povezava se odpre v novem oknu
UDK:615
ISSN pri članku:1999-4923
DOI:10.3390/pharmaceutics16091117 Povezava se odpre v novem oknu
COBISS.SI-ID:206005507 Povezava se odpre v novem oknu
Datum objave v RUL:19.09.2024
Število ogledov:93
Število prenosov:31
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Pharmaceutics
Skrajšan naslov:Pharmaceutics
Založnik:MDPI
ISSN:1999-4923
COBISS.SI-ID:517949977 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:rok uporabnosti, matrično oblikovanje, ICH Q1D, študija stabilnosti, kinetika razgradnje, parenteralne dozirne oblike, zdravila

Projekti

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P1-0189
Naslov:Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj